Evidence map›Paper›PMID 38511020›Full record

ArticleIndian journal of surgical oncology2024

Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Squamous Cell Carcinoma Esophagus: Demographics and Evaluation of Prognostic Factors at a Tertiary Care Center in India.

Mohamed Taher Mithi, Mohit Sharma, Ketul Puj, Prandweep Hazarika, Shashank J Pandya, Jahnavi Gandhi, Ankita Parikh, Shivang Shukla

Abstract read
In one paragraph

Article in Indian journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohamed Taher MithiDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.ORCID https://orcid.org/0000-0003-1989-4772
Mohit SharmaDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.ORCID https://orcid.org/0000-0002-9212-5120
Ketul PujDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.ORCID 0000-0003-0189-6112
Prandweep HazarikaDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.
Shashank J PandyaDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.
Jahnavi GandhiDepartment of Pathology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.
Ankita ParikhDepartment of Radiotherapy, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.
Shivang ShuklaDepartment of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat 380016 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neoadjuvant chemoradiation followed by surgery has been the standard of care for locally advanced carcinoma esophagus. We present our experience and inference of various factors associated with the same treatment and the prognostic influence of the same. A retrospective analysis of a cohort of 132 squamous cell carcinoma esophagus patients post neoadjuvant chemoradiation operated with curative intent was carried out. The 2-year overall survival rate was 64.5%. A pathological complete response was achieved in 32.5% of patients and was the only factor that significantly determined overall survival (

Indexed as

Esophageal cancerEsophagectomyNeoadjuvant chemoradiationPathological complete responseSquamous cell carcinoma

Identifiers

PMID38511020
PMCPMC10948642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.